Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Long-Term Investments: 2016-2025

Historic Long-Term Investments for Tg Therapeutics (TGTX) over the last 4 years, with Sep 2025 value amounting to $48.8 million.

  • Tg Therapeutics' Long-Term Investments rose 4233.96% to $48.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.8 million, marking a year-over-year increase of 4233.96%. This contributed to the annual value of $808,000 for FY2024, which is N/A change from last year.
  • Per Tg Therapeutics' latest filing, its Long-Term Investments stood at $48.8 million for Q3 2025, which was up 70.54% from $28.6 million recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Long-Term Investments registered a high of $48.8 million during Q3 2025, and its lowest value of $808,000 during Q4 2024.
  • Over the past 2 years, Tg Therapeutics' median Long-Term Investments value was $1.3 million (recorded in 2024), while the average stood at $11.9 million.
  • As far as peak fluctuations go, Tg Therapeutics' Long-Term Investments slumped by 65.09% in 2022, and later skyrocketed by 4,233.96% in 2025.
  • Tg Therapeutics' Long-Term Investments (Quarterly) stood at $35.5 million in 2021, then slumped by 65.09% to $12.4 million in 2022, then reached $808,000 in 2024, then soared by 4,233.96% to $48.8 million in 2025.
  • Its Long-Term Investments stands at $48.8 million for Q3 2025, versus $28.6 million for Q2 2025 and $1.9 million for Q1 2025.